Overview
City Therapeutics is a next generation RNAi company. The company will be developing a new approach to targeting that will enable the use of a novel cleavage mechanism which will allow for the use of smaller RNAi that will be more efficient, easier to deliver, and less expensive to manufacture. In addition, this approach will be able to target cells and tissues that are inaccessible by current technology.